Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc.
City of Hope Medical Center
AIDS Malignancy Consortium
City of Hope Medical Center
Boston Medical Center
National Cancer Institute (NCI)